43rd
GIRP Annual General Assembly
Conference
proceedings
GIRP
2002 - ‘Access to medicines for European citizens – Full-line
wholesalers – The vital link’
Mr
Christian Babuziaux, First Adviser Court of Auditors, President of the
Health Insurance Unit, Past Director General of Competition, Consumption
and Anti-Fraud Unit: ‘Distribution of medicines in France
and free movement in Europe’
Mr
Luc Gyselen, European Commission, DG Competition, Head of Unit: agricultural,
food- and pharmaceutical products: ‘Competition law &
the free movement of goods’
Mr
Gilles Brisson, Chairman of the Board of Directors of Aventis Pharma France:
‘Manufacturers expectations of the pharmaceutical wholesale
industry’
Mr
Gilles Pajot, Executive Vice President & President European region,
IMS: ‘Pharmaceutical market: scenarios for the future’
Mr
Philippe Luscan, Director Supply Chain of Sanofi-Synthelabo,
Mr François Blanot, Commercial Director and Operation Support for Sanofi-Synthelabo:
‘Exchange of information between pharmaceutical manufacturers and wholesalers’
Mr François Blanot, Commercial Director and Operation Support for Sanofi-Synthelabo:
‘Exchange of information between pharmaceutical manufacturers and wholesalers’
Dr.
Reiner Brettenthaler, CP (Standing Committee of European Doctors) President:
‘Collaboration between doctors and pharmacies to improve
primary health care’
Mr
William Darling, PGEU (Pharmaceutical Group of the European Union) President:
'Independent pharmacies and new tendencies in Europe'
Mr
John Kane, Consultant and former Chief Operating Officer of Cardinal Health:
‘Trends in the US pharmaceutical wholesale market’